| Bioactivity | DSPE-PEG(2000)-Mannose can be used to construct liposome vaccines to improve the anti-tumor effect of vaccines[1]. |
| CAS | 1829524-73-3 |
| Molar Mass | 3132 (Approximately) |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhao Y, et al. Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice. Int J Nanomedicine. 2020 Dec 1;15:9571-9586. |
DSPE-PEG(2000)-Mannose
CAS: 1829524-73-3 F: W: 3132 (Approximately)
DSPE-PEG(2000)-Mannose can be used to construct liposome vaccines to improve the anti-tumor effect of vaccines.
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.